Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 Diabetes

Diabetes. 2015 Dec;64(12):3990-2. doi: 10.2337/dbi15-0019.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Autoimmunity / drug effects*
  • CD3 Complex / chemistry*
  • Chemokine CXCL10 / antagonists & inhibitors*
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Disease Models, Animal*
  • Female
  • Islets of Langerhans / drug effects*

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Chemokine CXCL10